Stocktoria
LISATA THERAPEUTICS, INC. LSTA
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 1995-11-03
LISATA THERAPEUTICS, INC. statistics & valuation
Market cap$30.6M
P / B2.1×
Net margin-9756.5%
Return on equity-111.7%
FCF margin-9398.2%
Return on capital-124.1%
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | -10711.2% | -2240.9% | — | — | — | — | — | — | — | -83.6% |
| Net margin | -9756.5% | -1998.5% | — | — | — | — | — | — | — | -92.6% |
| FCF margin | -9398.2% | -1935.6% | — | — | — | — | — | — | — | -83.1% |
| Return on assets | -93.5% | -57.1% | -38.1% | -74.2% | -28.3% | -22.6% | -71.3% | -36.3% | 36.3% | -61.0% |
| Return on equity | -111.7% | -67.6% | -43.3% | -81.4% | -29.8% | -25.1% | -93.0% | -42.9% | 45.5% | -668.7% |
| Debt / equity | — | — | — | — | — | — | — | — | 0.00× | 0.52× |
| Current ratio | 5.76 | 6.16 | 8.18 | 11.26 | 21.27 | 10.08 | 4.35 | 7.85 | 6.59 | 1.16 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.